4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects.
Krystof V, Cankar P, Frysová I, Slouka J, Kontopidis G, Dzubák P, Hajdúch M, Srovnal J, de Azevedo WF Jr, Orság M, Paprskárová M, Rolcík J, Látr A, Fischer PM, Strnad M.
Krystof V, et al. Among authors: hajduch m.
J Med Chem. 2006 Nov 2;49(22):6500-9. doi: 10.1021/jm0605740.
J Med Chem. 2006.
PMID: 17064068